Clayton Internal Medicine is categorized under Internal Medicine Doctors in Chesterfield, MO and active since 2005.
Clayton Internal Medicine was established in 2005, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Ernest T Rouse Iii at the company’s single location by writing to 222 South Woods Mill Road 520n, Chesterfield, Missouri MO 63017 or by phoning (314) 205-6839. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Clayton Internal Medicine |
Contact Person: | Ernest T Rouse Iii |
Address: | 222 South Woods Mill Road 520n, Chesterfield, Missouri 63017 |
Phone Number: | (314) 205-6839 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Clayton Internal Medicine was started in 2005 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Ernest T Rouse Iii for inquiries that concern Clayton Internal Medicine by calling the company number (314) 205-6839, as your correspondence is most welcome. Additionally, the physical location of the single location of Clayton Internal Medicine can be found at the coordinates 38.652656,-90.506653 as well as the street address 222 South Woods Mill Road 520n in Chesterfield, Missouri 63017.
For its online presence, you may visit Clayton Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.